TY - STD TI - Ruggeri P, Farina AR, Cappabianca L, Ianni N, Ragone M, Merolla S, et al. Neurotrophin and neurotrophin receptor involvement in human neuroblastoma. In: Neuroblastoma, Prof Hiroyuki Shimada (Ed.). InTech, doi:https://doi.org/10.5772/55536. ID - ref1 ER - TY - JOUR AU - Aleo, L. AU - Rocco, M. L. AU - Omar, B. AU - Micera, A. PY - 2016 DA - 2016// TI - Nerve growth factor: role in growth, differentiation and controlling cancer development JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0395-y DO - 10.1186/s13046-016-0395-y ID - Aleo2016 ER - TY - JOUR AU - Martin-Zanca, D. AU - Hughes, S. H. AU - Barbacid, M. PY - 1986 DA - 1986// TI - A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences JO - Nature VL - 319 UR - https://doi.org/10.1038/319743a0 DO - 10.1038/319743a0 ID - Martin-Zanca1986 ER - TY - JOUR AU - Klein, R. AU - Jing, S. AU - Namduri, V. AU - O’Rourke, E. AU - Barbacid, M. PY - 1991 DA - 1991// TI - The trk proto-oncogene encodes a receptor for nerve growth factor JO - Cell VL - 65 UR - https://doi.org/10.1016/0092-8674(91)90419-Y DO - 10.1016/0092-8674(91)90419-Y ID - Klein1991 ER - TY - JOUR AU - Coulier, F. AU - Kumar, R. AU - Ernst, M. AU - Klein, R. AU - Martin-Zanca, D. AU - Barnacid, M. PY - 1990 DA - 1990// TI - Human Trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain JO - Mol Cell Biol VL - 10 UR - https://doi.org/10.1128/MCB.10.8.4202 DO - 10.1128/MCB.10.8.4202 ID - Coulier1990 ER - TY - JOUR AU - Greco, A. AU - Pierotti, M. A. AU - Bongarzone, I. AU - Pagliardi, S. AU - Lanzi, C. AU - Della Porta, G. PY - 1992 DA - 1992// TI - Trk-T1 is a novel oncogene formed by the fusion of TPR and Trk genes in human papillary thyroid carcinomas JO - Oncogene VL - 7 ID - Greco1992 ER - TY - JOUR AU - Greco, A. AU - Mariani, C. AU - Miranda, C. AU - Lupas, A. AU - Pagliardini, S. AU - Pomati, M. PY - 1995 DA - 1995// TI - The DNA rearrangement that generates the TrkT3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain JO - Mol Cell Biol VL - 15 UR - https://doi.org/10.1128/MCB.15.11.6118 DO - 10.1128/MCB.15.11.6118 ID - Greco1995 ER - TY - JOUR AU - George, D. J. AU - Suzuki, H. AU - Bova, S. G. AU - Isaacs, J. T. PY - 1998 DA - 1998// TI - Mutational analysis of the TrkA gene in prostate cancer JO - Prostate VL - 36 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - George1998 ER - TY - JOUR AU - Reuther, G. W. AU - Lambert, Q. T. AU - Caligiuri, M. A. AU - Der, C. J. PY - 2000 DA - 2000// TI - Identification and characterisation of an activating TrkA deletion mutation in acute myeloid leukemia JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.23.8655-8666.2000 DO - 10.1128/MCB.20.23.8655-8666.2000 ID - Reuther2000 ER - TY - JOUR AU - Wiesner, T. AU - He, J. AU - Yelensky, R. AU - Esteve-Puig, R. AU - Botton, T. AU - Yeh, I. PY - 2014 DA - 2014// TI - Kinase fusions are frequent in Spitz tumours and Spizoid melanomas JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4116 DO - 10.1038/ncomms4116 ID - Wiesner2014 ER - TY - STD TI - Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, et al. Sensitivity to entrectinib associated with a novel LMNA-NTRK1 gene fusion in metastatic colorectal cancer. J Natl Cancer Inst. 2016;108 https://doi.org/10.1093/jnci/djv306. ID - ref11 ER - TY - STD TI - Wong V, Pavlick D, Brennan T, Yelensky R, Crawford J, Ross JS, et al. Evaluation of a congenital infantile fibrosarcoma by comprehensive genomic profiling reveals an LMNA-NTRK gene fusion responsive to crizotinib. J Natl Cancer Inst. 2016;108 https://doi.org/10.1093/jnci/djv307. ID - ref12 ER - TY - JOUR AU - Lockwood, W. W. AU - Chari, R. AU - Coe, B. P. AU - Girard, L. AU - MacAulay, C. AU - lam, S. PY - 2008 DA - 2008// TI - DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.98 DO - 10.1038/onc.2008.98 ID - Lockwood2008 ER - TY - JOUR AU - Lee, S. J. AU - Kim, N. K. D. AU - Lee, S. -. H. AU - Kim, S. T. AU - Park, S. H. AU - Park, J. O. PY - 2017 DA - 2017// TI - NTRK gene amplification in patients with metastatic cancer JO - Prec Futur Med VL - 1 UR - https://doi.org/10.23838/pfm.2017.00142 DO - 10.23838/pfm.2017.00142 ID - Lee2017 ER - TY - JOUR AU - Amatu, A. AU - Sartore-Bianchi, A. AU - Siena, S. PY - 2016 DA - 2016// TI - NTRK gene fusions as novel targets of cancer therapy across multiple tumour types JO - ESMO Open VL - 1 UR - https://doi.org/10.1136/esmoopen-2015-000023 DO - 10.1136/esmoopen-2015-000023 ID - Amatu2016 ER - TY - JOUR AU - Vaishnavi, A. AU - Le, A. T. AU - Doeble, R. C. PY - 2015 DA - 2015// TI - TRKing down an old oncogene in a new era of targeted therapy JO - Cancer Disc VL - 5 UR - https://doi.org/10.1158/2159-8290.CD-14-0765 DO - 10.1158/2159-8290.CD-14-0765 ID - Vaishnavi2015 ER - TY - STD TI - Lange AM, Lo H-W. Inhibiting TRK proteins in clinical Cancer therapy. Cancers. 2018;10 https://doi.org/10.3390/cancers10040105. ID - ref17 ER - TY - JOUR AU - Drilon, A. AU - Laetsch, T. W. AU - Kummer, S. AU - DuBois, S. G. AU - Lassen, U. N. AU - Demetri, G. D. PY - 2018 DA - 2018// TI - Efficacy of Larotrectinib in Trk-fusion-positive cancer in adults and children JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1714448 DO - 10.1056/NEJMoa1714448 ID - Drilon2018 ER - TY - JOUR AU - Tacconelli, A. AU - Farina, A. R. AU - Cappabianca, L. AU - DeSantis, G. AU - Tessitore, A. AU - Vetuschi, A. PY - 2004 DA - 2004// TI - TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma JO - Cancer Cell VL - 6 UR - https://doi.org/10.1016/j.ccr.2004.09.011 DO - 10.1016/j.ccr.2004.09.011 ID - Tacconelli2004 ER - TY - JOUR AU - Schramm, A. AU - Schowe, B. AU - Fielitz, K. AU - Heilman, M. AU - Martin, M. AU - Marshall, T. PY - 2012 DA - 2012// TI - Exon-level expression analysis identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict neuroblastoma outcome JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.391 DO - 10.1038/bjc.2012.391 ID - Schramm2012 ER - TY - JOUR AU - Simpson, A. M. AU - Iyer, R. AU - Mangino, J. L. AU - Minturn, J. E. AU - Zhao, H. AU - Kolla, V. PY - 2012 DA - 2012// TI - TrkAIII isoform expression upregulates stem cell markers and correlates with worse outcome in neuroblastomas (NBs) JO - Proc Adv Neuroblast Res VL - 164 ID - Simpson2012 ER - TY - JOUR AU - Luberg, K. AU - Park, R. AU - Aleksejeva, E. AU - Timmusk, T. PY - 2015 DA - 2015// TI - Novel transcripts reveal a complex structure of the human TrkA gene and imply the presence of multiple protein isoforms JO - MBC Neurosci VL - 16 ID - Luberg2015 ER - TY - STD TI - Farina AR, Cappabianca L, Ruggeri P, Di Ianni N, Ragone M, Merolla S, et al. Alternative TrkA splicing and neuroblastoma. In: Neuroblastoma - Present and Future. London: Prof Hiroyuki Shimada (Ed) ISBN:978–953–307-016-2. InTech. 2012:111–136. ID - ref23 ER - TY - JOUR AU - Florenes, V. A. AU - Maelandsmo, G. M. AU - Holm, R. AU - Reich, R. AU - Lazarovici, P. AU - Davidson, B. PY - 2004 DA - 2004// TI - Expression of activated TrkA protein in melanocytic tumors JO - Am J Clin Pathol VL - 122 UR - https://doi.org/10.1309/CHFHEYAT44WWP7J3 DO - 10.1309/CHFHEYAT44WWP7J3 ID - Florenes2004 ER - TY - JOUR AU - Pasini, L. AU - Re, A. AU - Tebaldi, T. AU - Ricci, G. AU - Boi, S. AU - Adami, V. PY - 2015 DA - 2015// TI - TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1791-y DO - 10.1186/s12885-015-1791-y ID - Pasini2015 ER - TY - JOUR AU - Farina, A. R. AU - Tacconelli, A. AU - Cappabianca, L. AU - Cea, G. AU - Panella, S. AU - Chioda, A. PY - 2009 DA - 2009// TI - The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability JO - Mol Cell Biol VL - 29 UR - https://doi.org/10.1128/MCB.00352-09 DO - 10.1128/MCB.00352-09 ID - Farina2009 ER - TY - JOUR AU - Tacconelli, A. AU - Farina, A. R. AU - Cappabianca, L. AU - Cea, G. AU - Panella, S. AU - Chioda, A. PY - 2007 DA - 2007// TI - TrkAIII expression in the thymus JO - J Neuroimmunol VL - 183 UR - https://doi.org/10.1016/j.jneuroim.2006.12.005 DO - 10.1016/j.jneuroim.2006.12.005 ID - Tacconelli2007 ER - TY - JOUR AU - Gan, H. K. AU - Cvrljevic, A. N. AU - Johns, T. G. PY - 2013 DA - 2013// TI - The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered JO - FEBS J VL - 280 UR - https://doi.org/10.1111/febs.12393 DO - 10.1111/febs.12393 ID - Gan2013 ER - TY - JOUR AU - Tacconelli, A. AU - Farina, A. R. AU - Cappabianca, L. AU - Gulino, A. AU - Mackay, A. R. PY - 2005 DA - 2005// TI - Alternative TrkAIII splicing: a potential regulated tumor promoting switch in neuroblastoma JO - Future Oncol VL - 1 UR - https://doi.org/10.2217/14796694.1.5.689 DO - 10.2217/14796694.1.5.689 ID - Tacconelli2005 ER - TY - JOUR AU - Kavsan, V. M. AU - Iershov, A. V. AU - Balynska, O. V. PY - 2011 DA - 2011// TI - Immortalized cells and one oncogene in malignant transformation: old insights on new explanation JO - BMC Cell Biol VL - 12 UR - https://doi.org/10.1186/1471-2121-12-23 DO - 10.1186/1471-2121-12-23 ID - Kavsan2011 ER - TY - JOUR AU - Arevalo, J. C. AU - Conde, B. AU - Hempstead, B. L. AU - Chao, M. V. AU - Martin-Zanca, D. AU - Perez, P. PY - 2000 DA - 2000// TI - TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.16.5908-5916.2000 DO - 10.1128/MCB.20.16.5908-5916.2000 ID - Arevalo2000 ER - TY - JOUR AU - Farina, A. R. AU - Cappabianca, L. AU - Gneo, L. AU - Ruggeri, P. AU - Mackay, A. R. PY - 2018 DA - 2018// TI - TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation JO - Oncotarget VL - 9 UR - https://doi.org/10.18632/oncotarget.23618 DO - 10.18632/oncotarget.23618 ID - Farina2018 ER - TY - JOUR AU - Mossé, Y. P. AU - Laudenslager, M. AU - Longo, L. AU - Cole, K. A. AU - Wood, A. AU - Laquaglia, M. J. PY - 2008 DA - 2008// TI - Identification of ALK as a major familial neuroblastoma predisposition gene JO - Nature VL - 455 UR - https://doi.org/10.1038/nature07261 DO - 10.1038/nature07261 ID - Mossé2008 ER - TY - JOUR AU - Boutterin, M. C. AU - Mazot, P. AU - Faure, C. AU - Doly, S. AU - Gervasi, N. AU - Tremblay, M. I. PY - 2013 DA - 2013// TI - Control of ALK (wild type and mutated forms) phosphorylation: specific role for the phosphatase PTP1B JO - Cell Signal VL - 25 UR - https://doi.org/10.1016/j.cellsig.2013.02.020 DO - 10.1016/j.cellsig.2013.02.020 ID - Boutterin2013 ER - TY - JOUR AU - Shi, W. AU - George, S. K. AU - George, B. AU - Curry, C. V. AU - Murzabdillaeva, A. AU - Alkan, S. PY - 2017 DA - 2017// TI - TrkA is a binding partner of NPM-Alk that promotes survival of ALK+ T-cell lymphoma JO - Mol Oncol VL - 11 UR - https://doi.org/10.1002/1878-0261.12088 DO - 10.1002/1878-0261.12088 ID - Shi2017 ER - TY - JOUR AU - Brodeur, G. M. PY - 2018 DA - 2018// TI - Spontaneous regression of neuroblastoma JO - Cell Tissue Res VL - 372 UR - https://doi.org/10.1007/s00441-017-2761-2 DO - 10.1007/s00441-017-2761-2 ID - Brodeur2018 ER - TY - JOUR AU - Bochetta, M. AU - Di Resta, I. AU - Powers, A. AU - Fresco, R. AU - Tosolini, A. AU - Testa, J. R. PY - 2000 DA - 2000// TI - Human mesothelioma cells are unusually susceptible to simian virus 40-mediated transformation and asbestos carcinogenicity JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.170207097 DO - 10.1073/pnas.170207097 ID - Bochetta2000 ER - TY - STD TI - IARC Monographs on the evaluation of carcinogenic risks to humans Malaria and some polyoma viruses (SV40, BK, JC and Merkel cell viruses) (World Health Organisation international agency for research of Cancer, Geneva Switerland) 2014;104:133–251. ID - ref38 ER - TY - JOUR AU - Iwakura, H. AU - Ariyasu, H. AU - Kanamoto, N. AU - Hosoda, K. AU - Nakao, K. AU - Kangawa, K. PY - 2008 DA - 2008// TI - Establishment of a novel neuroblastoma mouse model JO - Int J Oncol VL - 33 ID - Iwakura2008 ER - TY - JOUR AU - Farina, A. R. AU - Cappabianca, L. AU - Ruggeri, P. AU - Gneo, L. AU - Maccarone, R. AU - Mackay, A. R. PY - 2015 DA - 2015// TI - Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5802 DO - 10.18632/oncotarget.5802 ID - Farina2015 ER - TY - JOUR AU - Chen, J. AU - Crutchley, J. AU - Zhang, D. AU - Owzar, K. AU - Kastan, M. B. PY - 2017 DA - 2017// TI - Identification of a DNA damage-response alternative splicing pathway that regulates p53 and cellular senescence markers JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-0908 DO - 10.1158/2159-8290.CD-16-0908 ID - Chen2017 ER - TY - JOUR AU - Li, Z. AU - Vuong, J. K. AU - Zhang, M. AU - Stork, C. AU - Zheng, S. PY - 2017 DA - 2017// TI - Inhibition of nonsense-mediated RNA decay by ER stress JO - RNA VL - 23 UR - https://doi.org/10.1261/rna.058040.116 DO - 10.1261/rna.058040.116 ID - Li2017 ER - TY - JOUR AU - Goto, N. PY - 2008 DA - 2008// TI - Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins JO - Cancer Sci VL - 99 UR - https://doi.org/10.1111/j.1349-7006.2008.00840.x DO - 10.1111/j.1349-7006.2008.00840.x ID - Goto2008 ER - TY - JOUR AU - Eggert, A. AU - Grotzer, M. A. AU - Ikegaki, N. AU - Liu, X. G. AU - Evans, A. E. AU - Brodeur, G. M. PY - 2000 DA - 2000// TI - Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma JO - Med Pediatr Oncol VL - 35 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Eggert2000 ER - TY - JOUR AU - Eggert, A. AU - Grotzer, M. A. AU - Ikegaki, N. AU - Liu, X. G. AU - Evans, A. E. AU - Brodeur, G. M. PY - 2002 DA - 2002// TI - Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells JO - Cancer Res VL - 62 ID - Eggert2002 ER - TY - JOUR AU - Bergers, G. AU - Brekken, R. AU - McMahon, G. AU - Vu, T. H. AU - Itoh, T. AU - Tamaki, K. PY - 2000 DA - 2000// TI - Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35036374 DO - 10.1038/35036374 ID - Bergers2000 ER - TY - JOUR AU - Rodriguez-Manzaneque, J. C. AU - Lane, T. F. AU - Ortega, M. A. AU - Hynes, R. O. AU - Lawler, J. AU - Iruela-Arispe, M. L. PY - 2001 DA - 2001// TI - Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial cell growth factor JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.171460498 DO - 10.1073/pnas.171460498 ID - Rodriguez-Manzaneque2001 ER - TY - JOUR AU - Qi, J. H. AU - Ebrahem, Q. AU - Moore, N. AU - Murphy, G. AU - Claesson-Welsh, L. AU - Bond, M. PY - 2003 DA - 2003// TI - A novel function for tissue inhibitor of metalloproteinases-3 (TIMP-3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 JO - Nature Med VL - 9 UR - https://doi.org/10.1038/nm846 DO - 10.1038/nm846 ID - Qi2003 ER - TY - JOUR AU - Ruggeri, P. AU - Farina, A. R. AU - Di Ianni, N. AU - Cappabianca, L. AU - Ragone, M. AU - Ianni, G. PY - 2014 DA - 2014// TI - The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD-2 expression and activity at the mitochondria, within the context of a tumor stem cell-like phenotype JO - PLoS One VL - 15 UR - https://doi.org/10.1371/journal.pone.0094568 DO - 10.1371/journal.pone.0094568 ID - Ruggeri2014 ER - TY - JOUR AU - Farina, A. R. AU - Tacconelli, A. AU - Cappabianca, L. AU - Cea, G. AU - Chioda, A. AU - Romanelli, A. PY - 2009 DA - 2009// TI - The neuroblastoma tumour suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2009.256 DO - 10.1038/onc.2009.256 ID - Farina2009 ER - TY - JOUR AU - Farina, A. R. AU - Di Ianni, N. AU - Cappabianca, L. AU - Ruggeri, P. AU - Ragone, M. AU - Ianni, G. PY - 2013 DA - 2013// TI - TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype JO - Biomed Res Int VL - 2013 UR - https://doi.org/10.1155/2013/740187 DO - 10.1155/2013/740187 ID - Farina2013 ER - TY - JOUR AU - Moughamian, A. J. AU - Osborn, G. E. AU - Lazurus, J. E. AU - Maday, S. AU - Holzbauer, E. L. F. PY - 2013 DA - 2013// TI - Predered recruitment of dynactin to the microtubule plus end is required for efficient initiation of retrograde axonal transport JO - J Neurosci VL - 33 UR - https://doi.org/10.1523/JNEUROSCI.0935-13.2013 DO - 10.1523/JNEUROSCI.0935-13.2013 ID - Moughamian2013 ER - TY - JOUR AU - Watson, F. L. AU - Porcionatto, M. A. AU - Battacharyya, A. AU - Stiles, C. D. AU - Segal, R. A. PY - 1999 DA - 1999// TI - TrkA glycosylation regulates localisation and activity JO - J Neurobiol VL - 39 UR - https://doi.org/3.0.CO;2-4 DO - 3.0.CO;2-4 ID - Watson1999 ER - TY - STD TI - Farina AR, Cappabianca L, Ruggeri P, Gneo L, Mackay AR. The enemy from within: mislocalization of a compromised receptor as a mechanism for TrkAIII oncogenic activity. Cancer Cell Microenviron. 2016;3(1):1–5. https://doi.org/10.14800/com.1205. ID - ref54 ER - TY - JOUR AU - Johnson, A. AU - Bhattachary, N. AU - Hanna, M. AU - Pennington, J. G. AU - Schuh, A. AU - Wang, L. PY - 2015 DA - 2015// TI - TGF clusters COPII-coated transport carriers and promotes early secretory pathway organisation JO - EMBO J VL - 7 UR - https://doi.org/10.15252/embj.201489032 DO - 10.15252/embj.201489032 ID - Johnson2015 ER - TY - JOUR AU - Schectersen, L. C. AU - Hudson, M. P. AU - Ko, M. AU - Philippidou, P. AU - Akmentin, W. AU - Wiley, J. PY - 2010 DA - 2010// TI - Trk activation in the secretory pathway promotes Golgi fragmentation JO - Mol Cell Neurosci VL - 43 UR - https://doi.org/10.1016/j.mcn.2010.01.007 DO - 10.1016/j.mcn.2010.01.007 ID - Schectersen2010 ER - TY - JOUR AU - Prior, I. A. AU - Hancock, J. F. PY - 2012 DA - 2012// TI - Ras trafficking, localisation and compartmentalised signaling JO - Semin Cell Dev Biol VL - 23 UR - https://doi.org/10.1016/j.semcdb.2011.09.002 DO - 10.1016/j.semcdb.2011.09.002 ID - Prior2012 ER - TY - JOUR AU - Gneo, L. AU - Ruggeri, P. AU - Cappabianca, L. AU - Farina, A. R. AU - Di Ianni, N. AU - Mackay, A. R. PY - 2016 DA - 2016// TI - TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.13098 DO - 10.18632/oncotarget.13098 ID - Gneo2016 ER - TY - JOUR AU - Li, Y. AU - Guo, Y. AU - Tang, J. AU - Jiang, J. AU - Vhen, Z. PY - 2014 DA - 2014// TI - New insights into the roles of CHOP-induced apoptosis in ER stress JO - Acta Biochim Biophysi Sin VL - 46 UR - https://doi.org/10.1093/abbs/gmu048 DO - 10.1093/abbs/gmu048 ID - Li2014 ER - TY - STD TI - Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response and cancer cell fate. Frontiers in Oncol. 2017;7 https://doi.org/10.3389/fonc.2017.00078. ID - ref60 ER - TY - JOUR AU - Hetz, C. AU - Lee, A. -. W. AU - Gonzalez-Romero, D. AU - Thielen, P. AU - Castilla, J. AU - Soto, C. PY - 2008 DA - 2008// TI - Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis JO - Proc Nat Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0711094105 DO - 10.1073/pnas.0711094105 ID - Hetz2008 ER - TY - JOUR AU - Bakhoum, S. F. AU - Ngo, B. AU - Laughney, A. M. AU - Cavallo, J. -. A. AU - Murphy, C. J. AU - Ly, P. PY - 2018 DA - 2018// TI - Chromosomal instability drives metastasis through a cytosolic DNA response JO - Nature VL - 533 UR - https://doi.org/10.1038/nature25432 DO - 10.1038/nature25432 ID - Bakhoum2018 ER - TY - JOUR AU - Sarni, D. AU - Kerem, B. PY - 2017 DA - 2017// TI - Oncogene-induced replication stress drives genome instability and tumorigenesis JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18071339 DO - 10.3390/ijms18071339 ID - Sarni2017 ER - TY - JOUR AU - Ruan, L. AU - Zhou, C. AU - Jin, E. AU - Kucharavy, A. AU - Zhang, Y. AU - Wen, Z. PY - 2017 DA - 2017// TI - Cytosol proteostasis through importing of misfolded proteins into mitochondria JO - Nature VL - 543 UR - https://doi.org/10.1038/nature21695 DO - 10.1038/nature21695 ID - Ruan2017 ER - TY - JOUR AU - Libert, M. V. AU - Locasale, J. W. PY - 2016 DA - 2016// TI - The Warburg effect: how does it benefit cancer cells JO - Trends in Biochem Sci VL - 41 UR - https://doi.org/10.1016/j.tibs.2015.12.001 DO - 10.1016/j.tibs.2015.12.001 ID - Libert2016 ER - TY - JOUR AU - Lee, N. AU - Kim, D. PY - 2016 DA - 2016// TI - Cancer metabolism: Fuelling more than just growth JO - Mol Cells VL - 39 UR - https://doi.org/10.14348/molcells.2016.0310 DO - 10.14348/molcells.2016.0310 ID - Lee2016 ER - TY - JOUR AU - Menendez, J. A. AU - Joven, J. AU - Cufi, S. AU - Corominas-Faja, B. AU - Oliveras-Ferraros, C. AU - Cuyas, E. PY - 2013 DA - 2013// TI - The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells JO - Cell Cycle VL - 12 UR - https://doi.org/10.4161/cc.24479 DO - 10.4161/cc.24479 ID - Menendez2013 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - STD TI - Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – part II. Exp Op Ther Pat. 2017; https://doi.org/10.1080/13543776.2017.1297797. ID - ref69 ER - TY - STD TI - Suvarna V, Murahari M, Khan T, Chaubey P, Sangave P. Phytochemicals and PI3K inhibitors in Cancer - an insight. Front Pharmacol. 2017;8 https://doi.org/10.3389/fpharm.2017.00916. ID - ref70 ER - TY - JOUR AU - Janku, F. AU - Yap, T. A. AU - Meric-Bernstam, F. PY - 2018 DA - 2018// TI - Targeting PI3K pathway in cancer: are we making headway? JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/nrclinonc.2018.28 DO - 10.1038/nrclinonc.2018.28 ID - Janku2018 ER - TY - JOUR AU - Gupta, S. C. AU - Sundaram, C. AU - Reuter, S. AU - Aggarwal, B. B. PY - 2010 DA - 2010// TI - Inhibiting NF-kB activation by small molecules as a therapeutic strategy JO - Biochim Biophys Acta VL - 1799 UR - https://doi.org/10.1016/j.bbagrm.2010.05.004 DO - 10.1016/j.bbagrm.2010.05.004 ID - Gupta2010 ER - TY - JOUR AU - Booth, L. AU - Cazanave, S. C. AU - Hamed, H. A. AU - Yacoub, A. AU - Ogretmen, B. AU - Chen, C. -. S. PY - 2012 DA - 2012// TI - OSU-30102 suppresses GRP78/BiP expression that causes PERK-dependent increase in tumor cell killing JO - Cancer Biol Ther VL - 13 ID - Booth2012 ER - TY - STD TI - Vogler M. Targeting BCL2-proteins for the treatment of solid tumours. Adv Med. 2014;2014 https://doi.org/10.1155/2014/943648. ID - ref74 ER - TY - JOUR AU - Quinn, B. A. AU - Dash, R. AU - Azab, B. AU - Sarkar, S. AU - Das, S. K. AU - Kumar, S. PY - 2011 DA - 2011// TI - Targeting Mcl-1 for the therapy of cancer JO - Exp Op Invest Drugs VL - 20 UR - https://doi.org/10.1517/13543784.2011.609167 DO - 10.1517/13543784.2011.609167 ID - Quinn2011 ER - TY - JOUR AU - Song, Y. -. H. AU - Wang, J. AU - Nie, G. AU - Chen, Y. -. J. AU - Li, X. AU - Jiang, X. PY - 2017 DA - 2017// TI - MicroRNA-509-5p functions as an anti-oncogene in breast cancer via targeting SOD2 JO - Eur Rev Med Pharmacol Sci VL - 21 ID - Song2017 ER - TY - JOUR AU - Hempel, N. AU - Carrico, P. M. AU - Melendez, J. A. PY - 2011 DA - 2011// TI - Manganese superoxide dismutase (Sod2) redox-control of signaling events that drive metastasis JO - Anti Cancer Agents Med Chem VL - 11 UR - https://doi.org/10.2174/187152011795255911 DO - 10.2174/187152011795255911 ID - Hempel2011 ER - TY - JOUR AU - Von Karsdtedt, S. AU - Montinaro, A. AU - Walczak, H. PY - 2017 DA - 2017// TI - Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.28 DO - 10.1038/nrc.2017.28 ID - Von Karsdtedt2017 ER - TY - JOUR AU - Wu, X. AU - Wang, S. AU - Li, M. AU - Wang, A. AU - Zhou, Y. AU - Li, P. PY - 2017 DA - 2017// TI - Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy JO - Nano VL - 9 ID - Wu2017 ER - TY - JOUR AU - Dubuisson, A. AU - Micheau, O. PY - 2017 DA - 2017// TI - Antibodies and derivatives targeting DR4 and DR5 for cancer therapy JO - Antibodies VL - 6 UR - https://doi.org/10.3390/antib6040016 DO - 10.3390/antib6040016 ID - Dubuisson2017 ER - TY - JOUR AU - Ruggeri, P. AU - Cappabianca, L. AU - Farina, A. R. AU - Gneo, L. AU - Mackay, A. R. PY - 2016 DA - 2016// TI - NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis JO - Cell Death Discov VL - 2 UR - https://doi.org/10.1038/cddiscovery.2016.4 DO - 10.1038/cddiscovery.2016.4 ID - Ruggeri2016 ER - TY - JOUR AU - Bagatell, R. AU - Gore, L. AU - Egorin, M. J. AU - Ho, R. AU - Heller, G. AU - Boucher, N. PY - 2007 DA - 2007// TI - Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1892 DO - 10.1158/1078-0432.CCR-06-1892 ID - Bagatell2007 ER -